The role of ketamine and its enantiomer in managing depression and pain in cancer patients: A narrative review.
Journal of Anesthesia and Translational Medicine December 1, 2024 Michael S Bodnar, Sierra Barber, Heather S L Jim et al. 3 citations
Depression and pain are common comorbidities in cancer patients, and ketamine, a dissociative anesthetic, has shown potential in managing both. This review summarizes current literature on ketamine and its enantiomer, esketamine, in managing depression and pain in the oncologic population. Studies indicate that sub-anesthetic doses of intravenous ketamine and esketamine can alleviate...